"Drug-Eluting Stents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Stents that are covered with materials that are embedded with chemicals that are gradually released into the surrounding milieu.
Descriptor ID |
D054855
|
MeSH Number(s) |
E07.695.750.500
|
Concept/Terms |
Drug-Eluting Stents- Drug-Eluting Stents
- Drug Eluting Stents
- Drug-Eluting Stent
- Stent, Drug-Eluting
- Stents, Drug-Eluting
- Stents, Drug Eluting
Drug-Coated Stents- Drug-Coated Stents
- Drug Coated Stents
- Drug-Coated Stent
- Stent, Drug-Coated
- Stents, Drug-Coated
- Stents, Drug Coated
|
Below are MeSH descriptors whose meaning is more general than "Drug-Eluting Stents".
Below are MeSH descriptors whose meaning is more specific than "Drug-Eluting Stents".
This graph shows the total number of publications written about "Drug-Eluting Stents" by people in this website by year, and whether "Drug-Eluting Stents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2007 | 2 | 0 | 2 |
2008 | 2 | 0 | 2 |
2009 | 5 | 0 | 5 |
2010 | 1 | 0 | 1 |
2011 | 1 | 1 | 2 |
2012 | 2 | 0 | 2 |
2013 | 4 | 0 | 4 |
2014 | 4 | 0 | 4 |
2015 | 1 | 0 | 1 |
2016 | 3 | 0 | 3 |
2017 | 5 | 1 | 6 |
2019 | 1 | 1 | 2 |
2020 | 1 | 2 | 3 |
2021 | 1 | 2 | 3 |
2022 | 1 | 0 | 1 |
2023 | 2 | 0 | 2 |
2024 | 1 | 2 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Drug-Eluting Stents" by people in Profiles.
-
Joseph M, Krishna MM, Ezenna C, Pereira V, Ismayl M, Nanna MG, Bangalore S, Goldsweig AM. Short Versus One-Year Dual Antiplatelet Therapy After Percutaneous Coronary Intervention: an Updated Meta-Analysis. Am J Cardiol. 2025 Feb 15; 237:17-28.
-
King RM, Peker A, Epshtein M, Arends JM, Brochu AB, Raskett CM, Slazas KJ, Puri AS, Arthur AS, Fiorella D, Gounis MJ, Anagnostakou V. Active drug-coated flow diverter in a preclinical model of intracranial stenting. J Neurointerv Surg. 2024 Jun 17; 16(7):731-736.
-
Creeden T, Jones DW. "Evolution of Drug-Coated Devices for the Treatment of Chronic Limb Threatening Ischemia". Ann Vasc Surg. 2024 Oct; 107:76-83.
-
Machanahalli Balakrishna A, Ismayl M, Goldsweig AM, Peters LA, Alla VM, Velagapudi P, Zhao DX, Vallabhajosyula S. Intracoronary Imaging Versus Coronary Angiography Guidance for Implantation of Second and Third Generation Drug Eluting Stents in a Systematic Review and Meta-Analysis of Randomized Controlled Trials. Am J Cardiol. 2023 09 01; 202:100-110.
-
Dani SS, Majithia A, Ssemaganda H, Robbins S, Bertges DJ, Eldrup-Jorgensen J, Sedrakyan A, Levy M, Siami FS, Joynt Maddox KE, Matheny M, Secemsky E, Resnic F. Real-World Safety Analysis of Paclitaxel Devices Used for the Treatment of Peripheral Artery Disease. J Vasc Interv Radiol. 2023 07; 34(7):1157-1165.e8.
-
Machanahalli Balakrishna A, Ismayl M, Walters RW, Aboeata A, Gowda RM, Vallabhajosyula S, Goldsweig AM, Dahal K. Comparing Optical Coherence Tomography and Intravascular Ultrasound Guidance for Percutaneous Coronary Intervention: Trends and Outcomes 2010-2019. Curr Probl Cardiol. 2022 Sep; 47(9):101270.
-
Gill K, Servati N, Flahive J, Fraielli K. Safety and Efficacy of Triple Therapy With Ticagrelor or Prasugrel Versus Clopidogrel After Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction. J Cardiovasc Pharmacol Ther. 2021 11; 26(6):625-629.
-
Mir T, Shanah L, Ahmad U, Sattar Y, Chokshi B, Aggarwal A, Prakash P, Attique HB, Changal KH, Kumar K, Alraies C, Qureshi WT, Afonso L. Bioresorbable polymer and durable polymer metallic stents in coronary artery disease: a meta-analysis. Expert Rev Cardiovasc Ther. 2021 May; 19(5):445-456.
-
Reynolds MR, Gong T, Li S, Herzog CA, Charytan DM. Cost-Effectiveness of Coronary Artery Bypass Grafting and Percutaneous Coronary Intervention in Patients With Chronic Kidney Disease and Acute Coronary Syndromes in the US Medicare Program. J Am Heart Assoc. 2021 04 06; 10(7):e019391.
-
Qureshi WT, Mir T, Uddin MM, Nasir UB. Meta-Analysis of Prospective Studies of Risk stratification by Syntax Score for Unprotected Left Main Coronary Artery Revascularization. Am J Cardiol. 2021 05 01; 146:138-139.